Martin J. Sturgeon
Nessuna posizione attualmente
Provenienza dei contatti di primo grado di Martin J. Sturgeon
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
Subsidiary | Pharmaceuticals: Major | 8 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Martin J. Sturgeon tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
LifeCell Corp.
LifeCell Corp. BiotechnologyHealth Technology LifeCell Corp. develops and markets tissue repair products. The firm focuses on reconstructive, urogynecologic and orthopedic surgical procedures. Its products include alloderm, strattice, graft jacket, allocraftdbm and repliform. The company was founded in 1986 and is headquartered in Branchburg, NJ. | Biotechnology | Director/Board Member | |
Oakley, Inc.
Oakley, Inc. Apparel/FootwearConsumer Non-Durables Oakley, Inc. designs and manufactures sunglasses and accessories. Its optics brand portfolio includes Eye Safety Systems, Fox Racing, Mosley Tribes, Oakley, Oliver Peoples and Paul Smith Spectacles. The company was founded by James H. Jannard in 1975 and is headquartered in Foothill Ranch, CA. | Apparel/Footwear | Director/Board Member | |
KORU MEDICAL SYSTEMS, INC. | Medical Specialties | Chief Tech/Sci/R&D Officer | |
Orthovita, Inc.
Orthovita, Inc. Medical SpecialtiesHealth Technology Orthovita, Inc. engages in the development and commercialization of synthetic biologically-active tissue engineering products for restoration of the human skeleton. The company was incorporated in 1992 and is headquartered in Malvern, PA. | Medical Specialties | Director/Board Member | |
Bioenvision, Inc.
Bioenvision, Inc. Medical/Nursing ServicesHealth Services Bioenvision, Inc. engages in the acquisition, development, distribution, and marketing of compounds and technologies for the treatment of cancer. It also develops anti-infective technologies, which includes the OLIGON(R) technology. The company was founded by Christopher B. Wood on August 16, 1996 and is headquartered in New York, NY. | Medical/Nursing Services | Director/Board Member | |
Adolor Corp.
Adolor Corp. BiotechnologyHealth Technology Adolor Corp. is a biopharmaceutical company specializing in the discovery, development and commercialization of novel prescription pain management products. The company develops and commercializes of novel opioid receptor-targeted therapeutics designed to maintain or improve pain relief and reduce opioid-related side effects. Its commercial product ENTEREG is a small molecule, peripherally acting mu opioid receptor antagonist intended to block the adverse side effects of opioid analgesics like morphine, on the gastrointestinal tract without interfering with central nervous system and mediated analgesia. The company was founded in 1993 and is headquartered in Exton, PA. | Biotechnology | Director/Board Member | |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Director/Board Member | |
DFINE, Inc.
DFINE, Inc. Medical SpecialtiesHealth Technology DFINE, Inc.engages in the development and commercialization of medical device system for treating vertebral compression fractures. The company was founded by John H. Shadduck and Csaba Truckai in 2004 and is headquartered in South Jordan, UT. | Medical Specialties | Director/Board Member | |
Cerexa, Inc.
Cerexa, Inc. Pharmaceuticals: MajorHealth Technology Cerexa, Inc. develops biopharmaceutical products. It is focuses on developing, acquiring and commercializing antibiotics to treat life-threatening, hospital-based infections. Cerexa's compound PPI-0903 is a cephalosporin used in treatment for complicated skin and skin-structure infections, as well as community-acquired and hospital-acquired pneumonias. The company was founded in 2005 and is headquartered in Alameda, CA. | Pharmaceuticals: Major | Director/Board Member | |
AVEDRO, INC. | Medical Specialties | Director/Board Member | |
INTERCEPT PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chairman | |
GLAUKOS CORPORATION | Medical Specialties | Director/Board Member | |
GELESIS INC | Biotechnology | Chairman | |
Cerapedics, Inc.
Cerapedics, Inc. Pharmaceuticals: MajorHealth Technology Cerapedics, Inc. engaged in the provision of developing and commercializing novel osteobiologic products. It offers i-FACTOR Bone Graft, an advanced biologic that supported with level I evidence, and provides benefit ratio. The company was founded by Andrew J. Tofe and is headquartered in Westminster, CO. | Pharmaceuticals: Major | Director/Board Member | |
Auxillium Energy, Inc.
Auxillium Energy, Inc. Oil & Gas ProductionEnergy Minerals Auxillium Energy, Inc. is an exploration stage company. It engages in the investigation, acquisition, exploration and development of oil and gas properties in Alaska. The company was founded on November 9, 2009 and is headquartered in White Plains, NY. | Oil & Gas Production | Director/Board Member | |
Arteaus Therapeutics LLC
Arteaus Therapeutics LLC BiotechnologyHealth Technology Arteaus Therapeutics LLC develops therapies for migraine prevention. The company was founded by Dave Grayzel and Scott C. Chappel on July 15, 2011 and is headquartered in Cambridge, MA. | Biotechnology | Corporate Officer/Principal | |
RHYTHM PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member | |
Denison University | College/University | Undergraduate Degree | |
University of North Texas | College/University | Masters Business Admin | |
University of Kansas | College/University | Undergraduate Degree | |
University of San Diego | College/University | Graduate Degree | |
NXSTAGE MEDICAL, INC. | Medical Specialties | Director/Board Member | |
INSULET CORPORATION | Medical Specialties | Director/Board Member | |
Enobia Pharma, Inc.
Enobia Pharma, Inc. Pharmaceuticals: MajorHealth Technology Enobia Pharma, Inc. develops therapies to treat patients with ultra-rare and life-threatening genetic metabolic bone disorders. Its lead product candidate, asfotase alfa or ENB-0040, is a treatment for hypophosphatasia—a life-threatening disease that can cause skeletal deformity, severe muscle weakness and progressive damage to vital organs. The company was founded in 1997 and is headquartered in Montreal, Canada. | Pharmaceuticals: Major | Chairman | |
OrbiMed Advisors Private Equity
OrbiMed Advisors Private Equity Investment ManagersFinance OrbiMed Advisors Private Equity (OrbiMed Advisors Private Equity) is a private equity and venture capital subsidiary of Orbimed Advisors LLC founded in 1993 by Samuel D. Isaly. The firm is headquartered in New York and it has additional offices in San Francisco, Mumbai, Shanghai, Herzliya, Hong Kong and London. | Investment Managers | Private Equity Investor | |
RELYPSA INC | Pharmaceuticals: Major | Director/Board Member | |
FATE THERAPEUTICS, INC. | Biotechnology | Corporate Officer/Principal | |
ASCENDIS PHARMA A/S | Pharmaceuticals: Major | Director/Board Member | |
Hambro Resource Development, Inc. | Corporate Officer/Principal | ||
Allianz Asset Management of America LP
Allianz Asset Management of America LP Financial ConglomeratesFinance Part of Allianz SE, Allianz Asset Management of America LP provides investment services. The company is based in New York, NY. | Financial Conglomerates | Director of Finance/CFO | |
OrbiMed Capital GP IV LLC | Corporate Officer/Principal | ||
Allergan GI Corp.
Allergan GI Corp. BiotechnologyHealth Technology Allergan GI Corp. develops peptide therapeutics for the treatment of gastrointestinal disorders. It provides RM-493 a small-peptide melanocortin-4 receptor agonist, for the treatment of obesity and diabetes, and RM-131 a small-peptide ghrelin agonist, for the treatment of diabetic gastro paresis and other gastrointestinal functional disorders. The company was founded by Bart Henderson and Elizabeth Stoner in 2008 and is headquartered in Madison, NJ. | Biotechnology | Director/Board Member | |
AUDENTES THERAPEUTICS, INC. | Biotechnology | Chairman | |
Harvard Business School | College/University | Masters Business Admin Masters Business Admin | |
SCPHARMACEUTICALS INC. | Pharmaceuticals: Major | Director/Board Member | |
Adicet Therapeutics, Inc.
Adicet Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Adicet Therapeutics, Inc. operates as a biopharmaceutical company focuses on the development of cell immunotherapies. It engages in the design and development of immunotherapies for cancer and other disease indications with a focus on novel universal immune cell therapies. The company was founded by Aya Jakobovits in 2014 and is headquartered in Beverly Hills, CA. | Pharmaceuticals: Major | Director/Board Member | |
Urovant Sciences, Inc.
Urovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Sumitomo Chemical Co., Ltd., Urovant Sciences, Inc. is a pharmaceutical company that prioritizes diversity, equity, and inclusion in rewriting how care is provided in urology. The company is based in Irvine, CA and offers programs to improve patient care, with a current focus on overactive bladder. Urovant Sciences is expanding opportunities to help patients in and beyond, with links to marketed product sites for patients and healthcare professionals, plus patent information. Recently, Sumitovant Biopharma Ltd. announced that its parent company Sumitomo Pharma Co., Ltd. will combine its wholly owned subsidiaries to form Sumitomo Pharma America, Inc., which will include Urovant Sciences and other subsidiaries. | Pharmaceuticals: Major | Comptroller/Controller/Auditor | |
UROVANT SCIENCES LTD. | Pharmaceuticals: Major | Comptroller/Controller/Auditor | |
ARCUTIS BIOTHERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member |
Statistiche
Distribuzione geografica
Stati Uniti | 46 |
Israele | 2 |
Canada | 2 |
Cina | 2 |
Danimarca | 2 |
Settori
Health Technology | 35 |
Consumer Services | 6 |
Finance | 4 |
Commercial Services | 3 |
Consumer Non-Durables | 2 |
Posizioni
Director/Board Member | 50 |
Independent Dir/Board Member | 18 |
Director of Finance/CFO | 14 |
Corporate Officer/Principal | 9 |
Chairman | 8 |
Contatti più connessi
- Borsa valori
- Insiders
- Martin J. Sturgeon
- Connessioni Società